Form D · Pharmaceuticals
Egalet Corp
Wayne, PA · CIK 0001586105
Offering snapshot reported Feb 20, 2019 · SEC filing
- Reported sold
- $42.2M Offering amount: $42.2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 20, 2019 | Initial | $42,156,458 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-333147
COMMON STOCK/WARRANTS ISSUED AS PARTIAL CONSIDERATION FOR PURCHASE OF CERTAIN ASSETS OF IROKO PHARMACEUTICALS BY ISSUER/SUBSIDIARY AS PART OF JOINT PLAN OF REORGANIZATION AND VOLUNTARY PETITIONS FOR REORGANIZATION UNDER CH 11 OF US BANKRUPTCY CODE.
Source: Form D, filed Feb 20, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Barbara A. Carlin | Executive |
| Luke Duster | Director |
| Andrea Heslin Smiley | Director |
| Todd Holmes | Director |
| Joseph Mcinnis | Director |
| Matthew Pauls | Director |
| Robert S. Radie | Director, Executive |
| Patrick M. Shea | Executive |
| Mark Strobeck | Executive |
| Megan Timmins | Executive |
| Timothy P. Walbert | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
600 Lee Road, Suite 100
Wayne, PA, 19087
Wayne, PA, 19087